By Allison DeAngelis, Adam Feuerstein, and Elaine Chen

Jan. 14, 2026

Allison DeAngelis

[email protected]

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01.

Adam Feuerstein

[email protected]

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54.

Elaine Chen

[email protected]

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

How did an office clerk become CEO of a major pharmaceutical company? What’s “Project Prometheus”? And what’s next in drug R&D?

Allison, Adam, and Elaine are asking those questions live from the J.P. Morgan Healthcare Conference in San Francisco.

Advertisement

Then, ARCH Venture Partners co-founder and managing director Bob Nelsen takes the mic to discuss everything going on in D.C., China’s ascent in biomedical innovation, and the use of AI in biotech.

New Novo Nordisk CEO Mike Doustdar joins the podcast hosts live to discuss his first few months on the job and the company’s push to regain market share in the competitive obesity market.

For more on Doustdar, go here; to read about the cautious past R&D culture at Novo Nordisk, go here; for more on ARCH Venture Partners and its investment strategy, go here.

Advertisement

And to watch a live recording of the episode, click the video below.

Be sure to sign up for “The Readout LOUD” on Apple Podcasts, Spotify, or wherever you get your podcasts.

, , , , ,
Submit a correction requestReprints

  1. Allison DeAngelis

    Biotech Startups and Venture Capital Reporter

    Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01.

  2. Adam Feuerstein

    Senior Writer, Biotech

    Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54.

  3. Elaine Chen

    National Biotech Reporter

    Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.